Literature DB >> 18424723

Phospholipase D1 plays a key role in TNF-alpha signaling.

Swaminathan Sethu1, Grecia Mendez-Corao, Alirio J Melendez.   

Abstract

The primary characteristic features of any inflammatory or infectious lesions are immune cell infiltration, cellular proliferation, and the generation of proinflammatory mediators. TNF-alpha is a potent proinflammatory and immuno-regulatory cytokine. Decades of research have been focused on the physiological/pathophysiological events triggered by TNF-alpha. However, the signaling network initiated by TNF-alpha in human leukocytes is still poorly understood. In this study, we report that TNF-alpha activates phospholipase D1 (PLD1), in a dose-dependent manner, and PLD1 is required for the activation of sphingosine kinase and cytosolic calcium signals. PLD1 is also required for NFkappaB and ERK1/2 activation in human monocytic cells. Using antisense oligonucleotides to reduce specifically the expression of PLD isozymes showed PLD1, but not PLD2, to be coupled to TNF-alpha signaling and that PLD1 is required to mediate receptor activation of sphingosine kinase and calcium transients. In addition, the coupling of TNF-alpha to activation of the phosphorylation of ERK1/2 and the activation of NFkappaB were inhibited by pretreating cells with antisense to PLD1, but not to PLD2; thus, demonstrating a specific requirement for PLD1. Furthermore, use of antisense oligonucleotides to reduce expression of PLD1 or PLD2 demonstrated that PLD1 is required for TNF-alpha-induced production of several important cytokines, such as IL-1beta, IL-5, IL-6, and IL-13, in human monocytes. These studies demonstrate the critical role of PLD1 in the intracellular signaling cascades initiated by TNF-alpha and its functional role for coordinating the signals to inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18424723     DOI: 10.4049/jimmunol.180.9.6027

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Identifying genetic loci and spleen gene coexpression networks underlying immunophenotypes in BXD recombinant inbred mice.

Authors:  Rachel M Lynch; Sudhir Naswa; Gary L Rogers; Stephen A Kania; Suchita Das; Elissa J Chesler; Arnold M Saxton; Michael A Langston; Brynn H Voy
Journal:  Physiol Genomics       Date:  2010-02-23       Impact factor: 3.107

2.  Sphingosine kinase and sphingosine-1-phosphate: regulators in autoimmune and inflammatory disease.

Authors:  Ashley J Snider
Journal:  Int J Clin Rheumtol       Date:  2013-08-01

3.  Identification of novel anionic phospholipid binding domains in neutral sphingomyelinase 2 with selective binding preference.

Authors:  Bill X Wu; Christopher J Clarke; Nabil Matmati; David Montefusco; Nana Bartke; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2011-05-06       Impact factor: 5.157

Review 4.  Sphingosine kinase: Role in regulation of bioactive sphingolipid mediators in inflammation.

Authors:  Ashley J Snider; K Alexa Orr Gandy; Lina M Obeid
Journal:  Biochimie       Date:  2010-02-13       Impact factor: 4.079

5.  Lack of alpha-synuclein modulates microglial phenotype in vitro.

Authors:  Susan A Austin; Lalida Rojanathammanee; Mikhail Y Golovko; Eric J Murphy; Colin K Combs
Journal:  Neurochem Res       Date:  2011-03-08       Impact factor: 3.996

Review 6.  Sphingolipids in spinal cord injury.

Authors:  Zachary B Jones; Yi Ren
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-08-05

7.  Phospholipase D1 mediates TNFalpha-induced inflammation in a murine model of TNFalpha-induced peritonitis.

Authors:  Swaminathan Sethu; Peter N Pushparaj; Alirio J Melendez
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

8.  Phospholipase D1 regulation of TNF-alpha protects against responses to LPS.

Authors:  Marc-Andre Urbahn; Sonja Charlotte Kaup; Friedrich Reusswig; Irena Krüger; Martina Spelleken; Kerstin Jurk; Meike Klier; Philipp A Lang; Margitta Elvers
Journal:  Sci Rep       Date:  2018-07-03       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.